Percutaneous device closure of congenital and iatrogenic ventricular septal defects in adult patients

Catheterization and Cardiovascular Interventions

Volumn 77, Issue 2, 2011, Pages 260-267

  Al Kashkari, Wail ^a   Balan, Prakash ^a   Kavinsky, Clifford J ^a   Cao, Qi Ling ^a   Hijazi, Ziyad M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

amplatzer VSD occluder; congenital VSD; transcatheter closure

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONGENITAL HEART VENTRICLE SEPTUM DEFECT; DYSPNEA; ECHOCARDIOGRAPHY; ENDOCARDITIS; FATIGUE; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VALVE REPLACEMENT; HEART VENTRICLE SEPTUM DEFECT; HEART VENTRICLE TACHYCARDIA; HEMATOMA; HUMAN; IATROGENIC HEART VENTRICLE SEPTUM DEFECT; MALE; MEDICAL RECORD REVIEW; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; MORBIDITY; MORTALITY; MYOMECTOMY; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PULMONARY HYPERTENSION; PULMONARY VALVE STENOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEPTAL OCCLUDER; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHICAGO; FEMALE; HEART CATHETERIZATION; HEART INJURIES; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; IATROGENIC DISEASE; MALE; MIDDLE AGED; PATIENT SELECTION; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEPTAL OCCLUDER DEVICE; TREATMENT OUTCOME; VENTRICULAR SEPTUM; YOUNG ADULT;

EID: 79751523726     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22799     Document Type: Article

References (11)

1. Carminati M, Butera G, Chessa M, et al. Transcatheter closure of congenital ventricular septal defects: Results of the European registry. Eur Heart J 2007; 28: 2361-2368. (Pubitemid 47537785)
2. Holzer R, de Giovanni J, Walsh K, et al. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: Immediate and midterm results of an international registry. Cathet Cardiovasc Interv 2006; 68: 620-628. (Pubitemid 44546057)
3. Szkutnik M, Qureshi S, Kusa J, et al. Use of the amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects. Heart 2007; 93: 355-358. (Pubitemid 46579528)
4. Holzer R, Balzer D, Cao Q, et al. Device closure of muscular ventricular septal defects using the amplatzer muscular ventricular septal defect occluder: Immediate and mid-term results of a US registry. J Am Coll Cardiol 2004; 43: 1257-1263. (Pubitemid 38452604)
5. Knauth A, Lock J, Perry S, et al. Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation 2004; 110: 501-507. (Pubitemid 39031164)
6. Masura J, Gao W, Gavora P, et al. Percutaenous closure of perimembranous ventricular septal defects with the eccentric amplatzer device: Multicenter follow-up study. Pediat Cardiol 2005; 26: 216-219. (Pubitemid 41374459)
7. Holzer R, Balzer D, Amin Z, et al. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a US registry. Cathet Cardiovasc Interv 2004; 61: 196-201. (Pubitemid 38160617)
8. Boutin C, Musewe NN, Smallhorn JF, Dyck JD, Kobayashi T, Benson LN,. Echocardiographic follow-up of atrial septal defect after catheter closure by double-umbrella device. Circulation 1993; 88: 621-627. (Pubitemid 23228063)
9. ASE Guidelines and Standards. Available at:.
10. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, McGoon M, Naeije R, Olschewski H, Oudiz RJ, Torbicki A,. Diagnosis and assessment of pulmonary hypertension. J Am coll Cardiol 2009; 54: 55-66.
11. Mongeon FP, Burkhart HM, Ammash NM, Dearani JA, Li Z, Warnes CA, Connolly HM,. Indications and outcome of surgical closure of ventricular septal defect in adult. J Am Coll Cardiol Cardiovasc Interv 2010; 3: 290-297.